Showing results (1-10 of 315) with videos related to

Sort By:
Pageof 32
Hematological Oncology|June 9, 2021
Allogeneic stem cell transplant in non-Hodgkin lymphomas: Still an indication?Peter Dreger
Hematology/Oncology Clinics of North America|April 9, 2013
The evolving role of stem cell transplantation in chronic lymphocytic leukemiaPeter Dreger,
Hematology. American Society of Hematology. Education Program|December 17, 2009
Allotransplantation for chronic lymphocytic leukemiaPeter Dreger
Cancer Journal (Sudbury, Mass.)|August 16, 2021
Is There a Role for Cellular Therapy in Chronic Lymphocytic Leukemia?Peter Dreger
Haematologica|September 11, 2025
Do high-volume centers really save more lives? A call for scientific rigor and transparency. Response to Comment on: Does size matter? Center-specific characteristics and survival after allogeneic hematopoietic cell transplantation for acute myeloid leukemia: an analysis of the German Registry for Stem Cell Transplantation and Cell TherapyWolfgang Bethge, Peter Dreger,
Hematology. American Society of Hematology. Education Program|December 7, 2024
The role of stem cell transplant (auto and allo) in PTCL and CTCLPeter Dreger, Norbert Schmitz
Clinical Lymphoma, Myeloma & Leukemia|August 14, 2016
Treatment of Chronic Lymphocytic Leukemia With del(17p)/TP53 Mutation: Allogeneic Hematopoietic Stem Cell Transplantation or BCR-Signaling Inhibitors?Emili Montserrat, Peter Dreger
Mediterranean Journal of Hematology and Infectious Diseases|December 4, 2012
Autologous Stem Cell Transplantation for Chronic Lymphocytic Leukemia - Still a Valid Treatment Option, or is the Game Over?Fabienne McClanahan, Peter Dreger
Current Hematologic Malignancy Reports|February 6, 2015
Where does allogeneic stem cell transplantation fit in the treatment of chronic lymphocytic leukemia?Peter Dreger, Emili Montserrat, , et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|June 7, 2016
Current strategies for the diagnosis and management of chronic lymphocytic leukemia (CLL), with a focus on poor-risk CLL: A reviewFabienne Mc Clanahan, Peter Dreger
Pageof 32